본문 바로가기
KERD
논문KCI 등재

Stereotactic Body Radiotherapy for Early Stage Lung Cancer

Yasushi Nagata
대한암학회 (Korean Cancer Association)|2013.09|Cancer Research and Treatment|제45권 제3호|pp. 155-161

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Stereotactic body radiation therapyLung neoplasmsRadiosurgeryStereotactic ablative radiotherapyConformal radiotherapyEarly stage lung cancerStereotactic radiotherapy
주제분류의학일반

초록

Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathing control, target determination, treatment planning, and verifications. The history and current standard technique are reviewed. Clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are reviewed.

Abstract

Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathing control, target determination, treatment planning, and verifications. The history and current standard technique are reviewed. Clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are reviewed.

참고문헌 (22)

  1. Blomgren H, "Radiosurgery for tumors in the body: clinical experience using a new method", J Radiosurg, 1, pp.63~74 (1998)
  2. Uematsu M, "Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience", Cancer, 82, pp.1062~1070 (1998)
  3. Onishi H, "A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices", Int J Radiat Oncol Biol Phys, 56, pp.14~20 (2003)
  4. Negoro Y, "The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy", Int J Radiat Oncol Biol Phys, 50, pp.889~898 (2001)
  5. Uematsu M, "Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience", Int J Radiat Oncol Biol Phys, 51, pp.666~670 (2001)
  6. Nagata Y, "Clinical outcomes of a phase I", II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame, 2005, pp.63, 1427~1431
  7. Onimaru R, "Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers", Int J Radiat Oncol Biol Phys, 56, pp.126~135 (2003)
  8. Arimoto T, "Small volume multiple non-coplanar arc radiotherapy for tumors of the lund, head and neck and the abdominopelvic region, In CAR’98 Computer assisted radiology and surgery", pp.257~261 (1998), Elsevier
  9. Timmerman R, "Stereotactic body radiation therapy for inoperable early stage lung cancer", JAMA, 303, pp.1070~1076 (2010)
  10. Wulf J, "Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients", Int J Radiat Oncol Biol Phys, 60, pp.186~196 (2004)
  11. Xia T, "Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I", II non-small-cell lung cancer, 2006, pp.66, 117~125
  12. Baumann P, "Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy", J Clin Oncol, 27, pp.3290~3296 (2009)
  13. Fowler JF, "Sensitivity analysis of parameters in linearquadratic radiobiologic modeling", Int J Radiat Oncol Biol Phys, 73, pp.1532~1537 (2009)
  14. Onishi H, "Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study", Cancer, 101, pp.1623~1631 (2004)
  15. Takeda A, "Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing", Radiat Med, 26, pp.504~507 (2008)
  16. Nagata Y, "Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiother- apy Group", Int J Radiat Oncol Biol Phys, 75, pp.343~347 (2009)
  17. Corradetti MN, "Central-airway necrosis after stereotactic body-radiation therapy", N Engl J Med, 366, pp.2327~2329 (2012)
  18. Timmerman R, "Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer", J Clin Oncol, 24, pp.4833~4839 (2006)
  19. Inoue T, "Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination", Int J Radiat Oncol Biol Phys, 75, pp.683~687 (2009)
  20. Chang JY, "Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer", Int J Radiat Oncol Biol Phys, 72, pp.967~971 (2008)
  21. Miyamoto T, "Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen", Int J Radiat Oncol Biol Phys, 67, pp.750~758 (2007)
  22. Nagata Y, "Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency", Int J Radiat Oncol Biol Phys, 79, pp.660~669 (2011)

관련 논문AI추천

The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer:Evidence for Changing ParadigmsMax Dahele, Suresh Senan대한암학회 · Cancer Research and Treatment2011 · 제43권 제2호Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors박성광, 엄상화, 조흥래대한암학회 · Cancer Research and Treatment2014 · 제46권 제4호Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea김연실, 김재성, 김진희, 김학재, 문성호, 송상혁, 송시열, 안용찬, 윤선민, 장지현, 조문준대한암학회 · Cancer Research and Treatment2017 · 제49권 제3호A Survey of Stereotactic Body Radiotherapy in Korea계철승, 김미숙, 김우철, 김은석, 김진호, 김진희, 배선현, 양광모, 이규찬, 장아람, 장원일, 조선미대한암학회 · Cancer Research and Treatment2015 · 제47권 제3호Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience김수산, 송시열, 신영섭, 이세원, 장정윤, 지원준, 최은경, 최창민대한암학회 · Cancer Research and Treatment2023 · 제55권 제4호A Fusion Study on the Selection of Cyberknife Technique according to the Location of the Pulmonary Tumors김갑중, 김낙상, 김정호, 배석환, 서선열한국융합학회 · 한국융합학회논문지2019 · 제10권 제7호

이 간행물의 다른 논문 (12건)

Survival of Korean Adult Cancer Patients by Stage at Diagnosis, 2006-2010: National Cancer Registry Study신애선, 정규원, 이진수, 공현주, 오창모, 원영주pp. 162-171A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients권정혜, 김호영, 장근두, 한보람, 정주영, 김정한, 박건욱, 김효정, 김형수, 장대영, 최대로, 송헌호pp. 172-177How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution허대석, 김동완, 박진현, 이정옥, 김태민, 이세훈, 정두현, 김범석pp. 178-185Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation김지윤, 정수미, 유미령, 정미주pp. 186-192Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis김재원, 박노현, 김학재, 김태헌, 정현훈, 이응석, 송용상, 김희승pp. 193-201
원문 보기